Clinical Trials of a New Contraceptive Device -- Medicated R-Iud. Collaborative Study Group of IUD.

L Zhuang,Bo Yang,Honglei Yuan,Hsu M

1995-01-01

Biodemography and Social Biology

Abstract:More than half of reproductive-age women in China who practice contraception use the IUD. While studies have demonstrated that a single inert stainless steel ring can be retained for more than 20 years expulsion and pregnancy rates are comparatively high. On the other hand while pregnancy rates in TCu and VCu (copper-releasing IUDs) are low bleeding is rather common. The authors therefore designed a medicated r-shaped IUD of stainless steel copper and indomethacin in an attempt to create an effective IUD yet one prone to induce a lesser degree of bleeding and abdominal pain. The preliminary study of the device involving 250 IUD insertions and users conducted from September 1986 to June 1988 showed a relative method effectiveness. A nationwide study from October 1988 to June 1989 then compared the r-IUD against the TCu220c. 1000 medicated r-IUDs and 1000 TCu220cs were inserted and both groups followed for 48 months. There was a 98% follow-up rate for both groups. At 48 months post-insertion the gross cumulative pregnancy rate with IUD in situ was 2.24 in the r-IUD group and 2.12 in the TCu220c group; the corresponding number of ectopic pregnancy cases were 7 and 8. A low expulsion rate resulted for both devices although the medical removal rate for the TCu220c was 5.52 per 100 women significantly higher than that of the r-IUD. The continuation rate of 91.18/100 women in the r-IUD group was significantly higher than the 81.93 level in the TCu220c group. Menstrual blood loss (MBL) measurements before and after insertion indicated that for about 2 years the r-IUD reduced MBL by 17-25% while the TCu220c increased the level by 47-49% gradually declining after 1 year. Other findings are reported.